Spin it Again - Four More Go Through the Revolving Door From the World of Corporate Health Care to Top US Government Leadership Positions

DiscussionSo this round of revolving door transitions featured a top pharmaceutical company researcher going to a leadership position at the NIH, which was considered long ago as a producer or unbiased science; and one physician-manager and two pure managers going from big management consultancies to DHHS.  All these consultancies seem to have thriving businesses working with big commercial health care firms. So the Trump regime continues to stock top health care leadership positions with people from the commercial health care world.  These leadership positions will allow them to to control contracting with, policies that affect, and regulation of big health care corporations, including those they worked with or for, and their competitors, for that matter.So, as I have said before, e.g.,three andfour months ago,The revolving door is a species ofconflict of interest. Worse, some experts have suggested that the revolving door is in fact corruption.  As we notedhere, theexperts from the distinguished European anti-corruption group U4 wrote,The literature makes clear that the revolving door process is a source of valuable political connections for private firms. Butit generates corruption risks and has strong distortionary effects on the economy, especially when this power is concentrated within a few firms.The ongoing parade of people transiting the revolving door from industry to the Trump regime once again suggests how the revolving door may enable certain of th...
Source: Health Care Renewal - Category: Health Management Tags: CMS conflicts of interest DHHS Donald Trump Eli Lilly McKinsey NIH revolving doors Veterans Affairs Source Type: blogs